Sheep Bluetongue Disease: Welfare Impacts and Vaccination Strategies

Bluetongue is a vector-borne viral disease of sheep and cattle spread by Culicoides midges. Outbreaks cause significant mortality and suffering in sheep, and vaccination is the primary prevention and welfare protection strategy.

Key Facts

Bluetongue virus (BTV) is transmitted by Culicoides biting midges and affects ruminants including sheep, cattle, goats, and deer; sheep suffer the most severe clinical disease
Clinical signs in sheep include fever, facial oedema, excessive salivation, ulceration of the mouth and muzzle, lameness, and the characteristic cyanotic tongue that gives the disease its name
Mortality rates in susceptible sheep populations can reach 70% in naive populations encountering virulent serotypes for the first time
The range of Culicoides midges has expanded northward in Europe due to climate change, bringing BTV serotypes 1 and 8 into the UK, Netherlands, and Scandinavia where sheep populations had no prior immunity
BTV serotype 3 emerged in the Netherlands in 2023 and spread rapidly through northern Europe in 2024-2025, causing widespread sheep and cattle deaths and major welfare emergencies
Vaccination provides strong protection when matched to the circulating serotype; however, vaccine development and regulatory approval take time, leaving populations vulnerable during novel serotype emergences
Movement restrictions imposed during outbreaks cause significant economic stress and can lead to welfare compromises from overcrowding when animals cannot be moved to suitable pasture

Welfare Considerations

Bluetongue causes intense suffering in affected sheep. Oral and nasal ulceration makes eating and drinking painful; foot lesions cause severe lameness; and in severe cases, tissue necrosis affects the tongue, lips, and coronary bands. Affected animals are visibly distressed and deteriorate rapidly without supportive treatment. Farmers managing outbreaks face the dual challenge of treating severely ill animals and preventing spread — the scale of care required during large outbreaks can exceed available resources, leading to welfare compromises. Vaccination campaigns that get ahead of emerging serotypes are the most effective welfare protection, but require proactive veterinary and policy planning.

What You Can Do

Vaccinate sheep flocks against bluetongue serotypes circulating in your region as soon as vaccines are available
Monitor DEFRA, APHA, or your national veterinary authority for bluetongue outbreak alerts and follow movement restriction guidance
Support investment in rapid vaccine development capacity for novel BTV serotypes to reduce the window of vulnerability during future outbreaks
Implement insect control measures including midge nets, repellents, and housing at dusk and dawn to reduce Culicoides exposure
Provide appropriate supportive care including NSAIDs for pain, soft palatable feed, and good nursing for affected animals
Advocate for government-funded emergency vaccine stockpiles for high-risk livestock diseases to enable rapid response to novel serotype incursions
Report any suspected bluetongue signs immediately to your veterinary surgeon and local animal health authority